Long-term survival after post-transplant lymphoproliferative disease in children
- 1 August 2002
- journal article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 17 (8) , 668-672
- https://doi.org/10.1007/s00467-002-0880-8
Abstract
Post-transplant lymphoproliferative disease (PTLD) is a well-known complication of immunosuppressive therapy. We present a series of 19 children who developed PTLD, following renal transplantation in 11 and liver transplantation in 8. The mean time between transplantation and the onset of PTLD was 19.5 months. Two patients had T-cell PTLD and died despite intensive chemotherapy. B-cell PTLD was observed in 17 patients and was associated with proven Epstein-Barr virus infection in 9. Despite immediate reduction of immunosuppressive therapy, only 8 of these 17 patients were alive at a 5.6-year mean follow-up. None of these patients had recurrence of PTLD when immunosuppression was resumed.Keywords
This publication has 0 references indexed in Scilit: